Webcast:

Gram-negative infections: recent guidelines and how to use diversity in antibiotic prescribing to improve clinical outcomes

Alt tag

Webcast:

Gram-negative infections:

recent guidelines and how to use diversity in antibiotic prescribing to improve clinical outcomes

About this webcast

In the webcast, Professor Mark Wilcox and Dr Vu Van Giap will illustrate the importance of diversity in antibiotic prescribing. Implementing this approach through rational therapy selection can improve clinical outcomes in different indications, including difficult-to-treat complicated urinary tract infections and pneumonia, in both hospital and community settings. A further benefit is that it also minimises antibiotic resistance.

Speakers

Associate Professor Vu Van Giap

Professor Mark Wilcox

Professor of Medical Microbiology,

University of Leeds, Leeds, UK

Professor Mark Wilcox is a Consultant Microbiologist and Head of Research and Development in Microbiology, Leeds Teaching Hospitals National Health Service Trust, Leeds, UK and Professor of Medical Microbiology, University of Leeds, UK. He is also Infection Lead of the National Institute for Health Research Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative.

Professor Mark Wilcox

Associate Professor Vu Van Giap

Associate Professor,

Hanoi Medical University, Hanoi, Vietnam

Associate Professor Van Giap is the Deputy Director, Respiratory Center, Bach Mai Hospital, Hanoi, Vietnam and an Associate Professor and Senior Lecturer at Hanoi Medical University, Vietnam. He is also currently a Postdoctoral Research Fellow at the University of Sydney in Australia.

If you have observed any unwanted or adverse effect, or have a quality complaint related to a Bayer product, we would be interested to hear about it as part of our ongoing pharmacovigilance processes. You may report these to us through our Bayer Side Effect Reporting website.